Emtricitabine is a nucleoside reverse transcriptase inhibitor (NRTI) used in the treatment and prevention of HIV infection by inhibiting viral replication. It is grouped under the following drug class(es): Dideoxynucleosides, DNA polymerase inhibitors, Nucleosides and Reverse Transcriptase Inhibitors. Its therapeutic use is listed as anti-infectives and antivirals. The directory classifies it as a commercial API with a synthetic source/manufacturing origin. Other names for this substance include Emtriva and Coviracil. Its PubChem CID is 60877.
Emtricitabine
| CAS No | 143491-57-0 |
|---|---|
| Molecular Formula | C8H10FN3O3S |
| Molecular Weight | 247.25 g/mol |
| Synonyms | 4-Amino-5-fluoro-1-[(2R,5S)-2-(hydroxymethyl)-1,3-oxathiolan-5-yl]-1,2-dihydropyrimidin-2-one |
Zoho Contact Form
"*" indicates required fields
Frequently Asked Questions
Emtricitabine is a nucleoside reverse transcriptase inhibitor (NRTI) used in the treatment and prevention of HIV infection by inhibiting viral replication. It is grouped under the following drug class(es): Dideoxynucleosides, DNA polymerase inhibitors, Nucleosides and Reverse Transcriptase Inhibitors.
The listed CAS number is 143491-57-0.
The listed molecular formula is C8H10FN3O3S.
The listed molecular weight is 247.25 g/mol.
4-Amino-5-fluoro-1-[(2R,5S)-2-(hydroxymethyl)-1,3-oxathiolan-5-yl]-1,2-dihydropyrimidin-2-one.
The source lists Emtriva and Coviracil.